matiullah khan
AIMST University
Bedong, Malaysia
Associate Editor
Cancer Molecular Targets and Therapeutics
AIMST University
Bedong, Malaysia
Associate Editor
Cancer Molecular Targets and Therapeutics
Vanderbilt University
Nashville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Cyprus
Nicosia, Cyprus
Associate Editor
Cancer Molecular Targets and Therapeutics
Roswell Park Comprehensive Cancer Center, University at Buffalo
Buffalo, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Kuribayashi Clinic
Oita City, Japan
Associate Editor
Cancer Molecular Targets and Therapeutics
Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Rutgers, The State University of New Jersey
New Brunswick, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
George Mason University
Fairfax, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Leonard M. Miller School of Medicine, University of Miami
Miami, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Shandong Cancer Hospital, Shandong University
Jinan, China
Associate Editor
Cancer Molecular Targets and Therapeutics
Indian Institute of Integrative Medicine (CSIR)
Jammu, India
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Brasilia
Brasilia, Brazil
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Naples Federico II
Naples, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
National Center for Drug Research and Evaluation, National Institute of Health (ISS)
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Tufts Medical Center
Boston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics